Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
153.96 USD | -0.93% | -2.78% | -12.84% |
Dec. 07 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Dec. 07 | Sector Update: Health Care Stocks Drop Thursday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
Pharmaceuticals
Calendar
2024-01-08
- J.P. Morgan Healthcare Conference
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
155.4USD
Average target price
174.91USD
Spread / Average Target
+12.55%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.84% | 374 B $ | |
+60.22% | 529 B $ | |
+42.56% | 430 B $ | |
-7.13% | 263 B $ | |
-7.65% | 261 B $ | |
+1.21% | 198 B $ | |
-9.95% | 197 B $ | |
-43.79% | 162 B $ | |
+2.66% | 145 B $ | |
-4.13% | 115 B $ |
- Stock
- Equities
- Stock Johnson & Johnson - Nyse
- News Johnson & Johnson
- Johnson & Johnson, Procter & Gamble Sued in Florida Over Decongestant Cold Medicines